Rigel Pharmaceuticals


Rigel Pharmaceuticals Stock Quote
$2.25 $0.03 1.4%
Price as of February 18, 2020, 4:30 p.m. EST View Interactive RIGL Charts

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Interactive Chart

News & Analysis: Rigel Pharmaceuticals

The Fool has written over 100 articles on Rigel Pharmaceuticals.


Market Moves


Is Rigel Pharmaceuticals a Buy?

The stock rose after a promising full-year 2018 earnings report and then rapidly began sliding back to multiyear lows. What's going on?